Showing results (121-130 of 222) with videos related to
Sort By:
Pageof 23
European Journal of Neurology|December 10, 2019
Language impairment in children aged 5 and 8 years after antiepileptic drug exposure in utero - the Norwegian Mother and Child Cohort StudyE S N Husebye, N E Gilhus, O Spigset, et al.Journal of Epidemiology and Community Health|April 18, 2003
Long term outcome after poliomyelitis in different health and social conditionsT Rekand, J Kõrv, E Farbu, et al.Journal of Neuroimmunology|January 1, 1995
Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cellsN E Gilhus, N Willcox, G Harcourt, et al.European Journal of Neurology|January 3, 2001
EFNS task force report: a questionnaire-based survey on the service provision and quality assurance for determination of diagnostic autoantibody tests in European neuroimmunology centres. European Federation of Neurological SocietiesH J Willison, W Ang, N E Gilhus, et al.Journal of Neuroimmunology|May 1, 1985
Skeletal muscle antibodies in patients with a thymic tumour but without myasthenia gravisN E Gilhus, J A Aarli, R W Janzen, et al.European Journal of Neurology|September 24, 2004
Guidance for the preparation of neurological management guidelines by EFNS scientific task forces--revised recommendations 2004M Brainin, M Barnes, J-C Baron, et al.European Journal of Neurology|January 11, 2002
Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravisF Romi, N E Gilhus, J E Varhaug, et al.Journal of Neuroimmunology|June 12, 2003
GM1 antibodies in post-polio syndrome and previous paralytic polioE Farbu, T Rekand, O-B Tysnes, et al.Muscle & Nerve|March 5, 1998
Myasthenia gravis sera containing antiryanodine receptor antibodies inhibit binding of [3H]-ryanodine to sarcoplasmic reticulumG O Skeie, P K Lunde, O M Sejersted, et al.Acta Physiologica Scandinavica|June 20, 2001
Autoimmunity against the ryanodine receptor in myasthenia gravisG O Skeie, P K Lunde, O M Sejersted, et al.Pageof 23